Overview

A multicenter, prospective, non-interventional, observational study to evaluate effectiveness and safety of sequential triple combination therapy (amlodipine/losartan/chlorthalidone) in Korean patients with hypertension

Eligibility

Inclusion Criteria:

1. Korean patients aged 19 years or older diagnosed with hypertension
2. Individuals newly diagnosed with hypertension or currently taking a single antihypertensive drug
3. Individuals for whom administration of Amoprel tablets has been determined based on the researcher's medical judgment
4. Individuals who have heard an explanation of this study and have voluntarily given written consent to participate in the study

Exclusion Criteria:

1. Individuals falling under the contraindications listed in the precautions for use of Amoprel Tab. or Amozartan Plus Tab.
2. Pregnant women, women who may be pregnant, and nursing mothers
3. Individuals currently participating in an interventional study
4. Individuals deemed unsuitable for participation in this study by the researcher for other reasons